Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: Targeting dendritic cells in autoimmunity

Journal of Inflammation

Volumn 7, Issue , 2010, Pages

  Jensen, Simon S ^a   Gad, Monika ^a  

^a BIONEER A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BIOLOGICAL MARKER; CCL15 CHEMOKINE; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HLA DR ANTIGEN; INDOMETACIN; INTERLEUKIN 12P70; INTERLEUKIN 23; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 2; PEPTIDOGLYCAN; POLYINOSINIC POLYCYTIDYLIC ACID; PROSTAGLANDIN E2; RESIQUIMOD; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL MATURATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; INFLAMMATION; PHENOTYPE; PROTEIN SECRETION; TARGET CELL; TH17 CELL;

EID: 77954870211     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-7-37     Document Type: Article

References (29)

1. Taking dendritic cells into medicine. RM Steinman J Banchereau, Nature 2007 449 27 419 426 10.1038/nature06175 17898760
2. Steady-state and inflammatory dendritic-cell development. K Shortman HN Shalin, Net Rev Immunol 2007 7 19 30 10.1038/nri1996 (Pubitemid 46020824)
3. Pathogen subversion of cell-intrinsic innate immunity. CR Roy ES Mocarski, Nat Immunol 2007 8 11 1179 1187 10.1038/ni1528 17952043
4. The immunological and genetic basis of inflammatory bowel disease. G Bouma W Strober, Nat Rev Immunol 2003 3 521 533 10.1038/nri1132 12876555
5. Chemokines: more than just road signs. MF Bachmann M Kopf BJ Marsland, Nat Rev Immunol 2006 6 159 164 10.1038/nri1776 16491140
6. Inhibitory B7-family molecules in the tumor microenvironment. W Zou L Chen, Nat Rev Immunol 2008 8 467 477 10.1038/nri2326 18500231
7. IL-23: a master regulator in Crohns disease. MF Neurath, Nat Med 2007 13 1 26 28 10.1038/nm0107-26 17206128
8. The IL-23 axis plays a key role in the pathogenesis of IBD. D McGovern F Powrie, Gut 2007 56 1333 1336 10.1136/gut.2006.115402 17872562
9. Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22. H Hammad HH Smits C Ratajczak A Nithiananthan EA Wierenga GA Stewart A Jacquet AB Tonnel J Pestel, Eur Cytokine Netw 2003 14 4 219 28 14715413
10. Tuning inflammation and immunity by chemokine sequestration: decoys and more. A Mantovani R Bonecchi M Locati, Nat Rev Immunol 2006 6 907 918 10.1038/nri1964 17124512
11. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. E Lee WL Trepicchio JL Oestreicher D Pittman F Wang F Chamian M Dhodapkar JG Krueger, J Exp Med 2004 199 1 125 30 10.1084/jem.20030451 14707118
12. The cytokine and chemokine network in psoriasis. BJ Nickoloff H Xin FO Nestle JZ Qin, Clin Dermatol 2007 25 6 568 73 10.1016/j.clindermatol.2007.08.011 18021894
13. Interleukin-12, interleukin-23, and psoriasis: current prospects. DC Torti SR Feldman, J Am Acad Dermatol 2007 57 6 1059 68 10.1016/j.jaad.2007.07. 016 17706835
14. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. H Hackstein AW Thomson, Nat Rev Immunol 2004 4 1 24 34 10.1038/nri1256 14704765
15. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. A Langenkamp M Messi A Lanzavecchia F Sallusto, Nature Immunology 2000 1 311 316 10.1038/79758 11017102
16. CD4 T cell-induced, bid-dependent apoptosis of cutaneous dendritic cells regulates T cell expansion and immune responses. S Pradhan J Genebriera WL Denning K Felix CA Elmets L Timares, J Immunol 2006 177 5956 67 17056520
17. Toll-like receptor signalling. S Akira K Takeda, Nat Rev Immunol 2004 4 499 511 10.1038/nri1391 15229469
18. Mammalian Toll-like receptors:to immunity and beyond. PA Hopkins S Sriskandan, Clin Exp Immmunol 2005 140 395 407 10.1111/j.1365-2249.2005.02801.x (Pubitemid 40813950)
19. The expression of toll-like Receptors 3 and 7 in Rheumatoid Arthritis Synovium Is Increased and Costimulation of Toll-like Receptors 3, 4 and 7/8 Results in Synergistic Cytokine Production by Dendritic Cells. MF Roelofs AB Joosten S Abdollahi-Roodsaz AWT van Lieshout T Sprong FH van den Hoogen WB van den Berg TRDJ Radstake, Arhtitis & Rheumatism 2005 52 8 2313 2322
20. Dendritic cells in intestinal immune regulation. JL Coombes F Powrie, Nature Immunology 2008 8 435 446 10.1038/nri2335 (Pubitemid 351733420)
21. Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. RB Mailliard A Wankowicz-Kalinska Q Cai A Wesa CM Hilkens ML Kapsenberg JM Kirkwood WJ Storkus P Kalinski, Cancer Res 2004 64 17 5934 7 10.1158/0008-5472.CAN-04-1261 15342370
22. Differential production of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists. RE Roses S Xu M Xu U Koldovsky G Koski BJ Czerniecki, J Immunol 2008 181 7 5120 7 18802116
23. Both IL-12p70 and IL-23 are synthesized during active Crohns disease and are down-regulated by treatment with anti-IL-12p40 monoclonal antibody. IJ Fuss C Becker Z Yang C Groden RL Hornung F Heller MF Neurath W Strober PJ Mannon, Inflamm Bowel Dis 2006 12 1 9 15 10.1097/01.MIB.0000194183.92671.b6 16374252
24. Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease. W Zhong JK Kolls H Chen F McAllister PD Oliver Z Zhang, Front Biosci 2008 13 1654 64 10.2741/2789 17981657
25. Inflammatory Bowel Disease: Epidemiology, pathogenesis and therapeutic opportunities. SB Hanauer, Inflamm Bowel Dis 2006 12 1 3 S9 10.1097/01.MIB. 0000195385.19268.68 16378007
26. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. M Gilliet C Conrad M Geiges A Cozzio W Thürlimann G Burg FO Nestle R Dummer, Arch Dermatol 2004 140 12 1490 5 10.1001/archderm.140.12.1490 15611427
27. Molecular aspects of rheumatoid arthritis:chemokines in joints of patients. G Iwamoto H Okamoto Y Toyama S Momohara, FEBS Journal 2008 275 18 4448 55 10.1111/j.1742-4658.2008.06580.x 18662305
28. Multiple sclerosis: a complicated picture of autoimmunity. HF McFarland R Martin, Nat Immunol 2007 8 9 913 9 10.1038/ni1507 17712344
29. Typer 17 T helper cells-origins, features and possible roles in rheumatic disease. F Annunziato L Cosmi F Liotta S Romagnani, Nat Rev Rheumatol 2009 5 6 325 31 10.1038/nrrheum.2009.80 19434074